Cargando…

COPD advances in left ventricular diastolic dysfunction

BACKGROUND: COPD is concomitantly present in ~30% of patients with heart failure. Here, we investigated the pulmonary function test parameters for left ventricular (LV) diastolic dysfunction and the relationship between pulmonary function and LV diastolic function in patients with COPD. PATIENTS AND...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kubota, Yoshiaki, Asai, Kuniya, Murai, Koji, Tsukada, Yayoi Tetsuou, Hayashi, Hiroki, Saito, Yoshinobu, Azuma, Arata, Gemma, Akihiko, Shimizu, Wataru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820215/ https://www.ncbi.nlm.nih.gov/pubmed/27099482 http://dx.doi.org/10.2147/COPD.S101082

Ejemplares similares

Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease
por: Kubota, Yoshiaki, et al.
Publicado: (2015)

Status of Medical Care and Management Requirements of Elderly Patients With Heart Failure in a Comprehensive Community Health System　― Survey of General Practitioners’ Views ―
por: Tsukada, Yayoi Tetsuou, et al.
Publicado: (2021)

Validation of wearable textile electrodes for ECG monitoring
por: Tsukada, Yayoi Tetsuou, et al.
Publicado: (2019)

Effect of Empagliflozin Versus Placebo on Cardiac Sympathetic Activity in Acute Myocardial Infarction Patients with Type 2 Diabetes Mellitus: Rationale
por: Kubota, Yoshiaki, et al.
Publicado: (2018)

Plaque Characteristics in Coronary Artery Disease Patients with Impaired Glucose Tolerance
por: Suzuki, Keishi, et al.
Publicado: (2016)

Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis
por: Inomata, Minoru, et al.
Publicado: (2014)

Chronic obstructive pulmonary disease and β‐blocker treatment in Asian patients with heart failure
por: Kubota, Yoshiaki, et al.
Publicado: (2017)

Effect of Empagliflozin Versus Placebo on Plasma Volume Status in Patients with Acute Myocardial Infarction and Type 2 Diabetes Mellitus
por: Hoshika, Yu, et al.
Publicado: (2021)

Empagliflozin confers reno‐protection in acute myocardial infarction and type 2 diabetes mellitus
por: Mozawa, Kosuke, et al.
Publicado: (2021)

Predictive Factors for Decreasing Left Ventricular Ejection Fraction and Progression to the Dilated Phase of Hypertrophic Cardiomyopathy
por: Ishihara, Kakeru, et al.
Publicado: (2023)

Prognostic Factors in the Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Retrospective Single-center Study
por: Atsumi, Kenichiro, et al.
Publicado: (2017)

Pulmonary embolism and deep vein thrombosis in eosinophilic granulomatosis with polyangiitis successfully treated with rivaroxaban
por: Naito, Tomoyuki, et al.
Publicado: (2018)

Prognostic values of highly sensitive cardiac troponin T and B-type natriuretic peptide for clinical features in hypertrophic obstructive cardiomyopathy: a cross-sectional study
por: Nakamura, Shunichi, et al.
Publicado: (2014)

Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial
por: Shimizu, Wataru, et al.
Publicado: (2020)

Awareness and Feasibility of Women Chairing Cardiology Sessions in Scientific Meetings: A Nationwide Survey by the Japanese Circulation Society
por: Nakayama, Atsuko, et al.
Publicado: (2022)

Does the treatment of left ventricular diastolic dysfunction improve the quality of life in advanced COPD patients?
por: Bhattacharyya, Parthasarathi, et al.
Publicado: (2012)

Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation
por: Kamio, Koichiro, et al.
Publicado: (2018)

Effect of Empagliflozin in Preventing Progression of Renal Dysfunction in Diabetic Patients With Compensated Heart Failure　― Reply ―
por: Shirakabe, Akihiro, et al.
Publicado: (2021)

Pulmonary sarcoidosis complicated by rheumatoid arthritis in a patient presenting with progressive fibrosing interstitial lung disease and treated with nintedanib: a case report and literature review
por: Suzuki, Ayana, et al.
Publicado: (2023)

Association of glycemic variability with left ventricular diastolic function in type 2 diabetes mellitus
por: Yokota, Shun, et al.
Publicado: (2019)

The clinical quandary of left and right ventricular diastolic dysfunction and diastolic heart failure
por: Schwarz, Ernst R, et al.
Publicado: (2010)

Pathophysiologic Contributions of Visceral Adiposity to Left Ventricular Diastolic Dysfunction
por: Nagata, Reika, et al.
Publicado: (2023)

Pseudo-postpacing interval of diastolic potential after entrainment pacing of remote bystander pathway in reentrant ventricular tachycardia
por: Kaneko, Yoshiaki, et al.
Publicado: (2013)

Relation between global end-diastolic volume and left ventricular end-diastolic volume
por: Pironet, A, et al.
Publicado: (2015)

Mitral Annular Dynamics and Left Ventricular Diastole
por: Lopez-Candales, Angel, et al.
Publicado: (2017)

Biomarkers of Inflammation in Left Ventricular Diastolic Dysfunction
por: Mocan, Mihaela, et al.
Publicado: (2019)

Left ventricular diastolic gradient in hypertrophic cardiomyopathy()
por: Pacelli, Filomena, et al.
Publicado: (2016)

Left Ventricular Diastolic Dysfunction in ARDS Patients
por: Formenti, Paolo, et al.
Publicado: (2022)

Diastolic function evaluation in children with ventricular arrhythmia
por: Pietrzak, Radosław, et al.
Publicado: (2023)

Decreased diastolic wall strain is associated with adverse left ventricular remodeling even in patients with normal left ventricular diastolic function
por: Kang, Min-Kyung, et al.
Publicado: (2014)

Does Premature Ventricular Complex Impair Left Ventricular Diastolic Functions?
por: Keleş, Nurşen, et al.
Publicado: (2023)

Clinical Benefits of Sodium–Glucose Cotransporter 2 Inhibitors and the Mechanisms Underlying Their Cardiovascular Effects
por: Kubota, Yoshiaki, et al.
Publicado: (2022)

Clinical features and long-term prognosis of patients with congestive heart failure taking tolvaptan: a comparison of patients with preserved and reduced left ventricular ejection fraction
por: Seki, Toshiki, et al.
Publicado: (2021)

Impact of beta‐blocker use on the long‐term outcomes of heart failure patients with chronic obstructive pulmonary disease
por: Kubota, Yoshiaki, et al.
Publicado: (2021)

Understanding the need of ventricular pressure for the estimation of diastolic biomarkers
por: Xi, Jiahe, et al.
Publicado: (2013)

Vitamin D levels and left ventricular diastolic function
por: Pandit, Anil, et al.
Publicado: (2014)

Right Ventricular Diastolic Function in Patients with Thalassemia Major
por: Demirkol, Sait, et al.
Publicado: (2013)

Hydraulic forces contribute to left ventricular diastolic filling
por: Maksuti, Elira, et al.
Publicado: (2015)

Decision support for assessment of left ventricular diastolic function
por: Tamás, Éva, et al.
Publicado: (2018)

Hydraulic forces contribute to left ventricular diastolic filling
por: Maksuti, Elira, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ddtd4pq16nhtqqdafkn2l1eu7f